epitaxy
by @fastdrop
Federal drug shortages and recalls joined to the federal contracts that buy those drugs.
Federal drug shortages and recalls joined to the federal contracts that buy those drugs. Official MCP Registry: xyz.crossgrain/epitaxy@0.1.3. Remote endpoint: https://drugs.crossgrain.xyz/v1/mcp
Problem it solves
Discoverable MCP server listed in the official MCP Registry.
How it's different
Remote MCP endpoint ingested from the official registry and probed by FastDrop.
Ingested from the official MCP Registry
FastDrop pulled this entry from the official MCP Registry as xyz.crossgrain/epitaxy and probed the endpoint. The maker did not submit it, so the outbound link is not endorsed
and the description is not theirs.
If this is your server, claim the listing to edit it and take ownership. The registry index lists everything else still awaiting a probe.
Claim this listingTools this endpoint exposes
Read directly from the endpoint on 8 Sept 2026. Not supplied by the maker.
get_data_freshnessReturns when the data was last activated, how many segments are live, and the state of the last run. Call this first when you need to know whether the data is fresh.
list_drug_shortagesCurrent and resolved US drug shortages as reported by the FDA. Each row carries the generic name, the reporting company and its company_id. Filters: status, generic_name, company_id, limit.
list_drug_recallsFDA drug recalls and enforcement reports. Filters: classification (Class I, II, III), company_id, limit.
list_federal_drug_contractsUS federal contracts for drugs, product service code 6505, from USAspending. Filters: agency, company_id, limit.
get_supplier_exposureThe join: a federal contract whose supplier has an FDA shortage or recall. Every row carries company_name, confidence (exact, probable or weak) and match_method. A cross source join is NEVER exact, be
Is this tool yours?
Claim this listing and we’ll verify ownership before handing it over.
Sign in to claim this listingRelated Products
Reviews
Sign in to leave a review.
No reviews yet.
Comments
Sign in to join the discussion.
No comments yet - start the discussion.